Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study


Fatty liver disease is one of the most common forms of chronic liver disease. The renin-angiotensin-aldosterone system has been implicated in the pathogenesis of fatty liver. The objective of the study was to determine the relationship between fatty liver and aldosterone in a large cohort study using the original Jackson Heart Study cohort which enrolled African American participants from the Jackson, Mississippi, metropolitan area in Hinds, Madison, and Rankin Counties. The study population consisted of 2507 Jackson Heart Study participants (1625 women and 882 men) who had liver attenuation measured per computed tomography scans, had aldosterone measurements, and were not taking angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or mineralocorticoid receptor antagonists. Univariate regression analysis demonstrated a statistically significant correlation between aldosterone levels and liver attenuation. Each doubling of aldosterone was associated with 1.08 Hounsfield unit decrease (95% confidence interval, 1.47 to −0.69, P < 0.001). A multivariable model adjusted for body mass index, age, alcohol intake, and homeostatic model assessment of insulin resistance determined that the association was statistically significant only for women. Our data demonstrate a positive association between aldosterone levels and fatty liver in African American women.

Authors: Aditi Kumar, Chad Blackshear, Jose S. Subauste, Nazanene H. Esfandiari, Elif Arioglu Oral, Angela R. Subauste
Keywords: fatty liver, African American, women
DOI Number: 10.1210/js.2017-00055      Publication Year: 2017

To search for other research papers by topic, keyword, author, or year, please go to our Publications page.